Found 18 matching trials
Ovarian Dendritic Cell Vaccine Trial
PHASE2The purpose of this study is to determine if a dendritic cell vaccine made ...
Location
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
PHASE1This study will test whether certain patients with myelodysplastic syndrome...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
PHASE1This randomized phase I trial studies the side effects and best way to give...
Location
University of Chicago
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PHASE3This is an event driven, adaptive design, a randomized, active-controlled, ...
Location
University of Alabama at Birmingham
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
PHASE2This trial will assess the safety and efficacy of vaccination with galinpep...
Location
Memorial Sloan Kettering Cancer Center
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers
PHASE2This study will test the safety and effectiveness of two vaccines on slowin...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.
PHASE2This study is an investigator-initiated clinical trial (Phase II) using DSP...
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
PHASE1The purpose of this phase I study is to investigate the combination of hypo...
Location
Dept of Hematology, Herlev Hospital
Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
PHASE2Study of galinpepimut-S, a Wilms Tumor-1 (WT1) vaccine, to see if it delays...
Location
Memorial Sloan Kettering Cancer Center
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
PHASE1The purpose of this trial is to assess the immune response after vaccinatio...
Location
Memorial Sloan Kettering Cancer Center